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Objective: To investigate the correlation between radiologic vascular dilatation
and serum nitrite concentration and eNOS expression in the endothelial cell and
pneumocyte in a rabbit model of hepatopulmonary syndrome induced by com-
mon bile duct ligation (CBDL).
Materials and Methods: Thin-section CT scans of the lung and pulmonary
angiography were obtained 3 weeks after CBDL (n=6), or a sham operation
(n=4), and intrapulmonary vasodilatation was assessed. The diameter and tortu-
osity of peripheral vessels in the right lower lobe by thin-section CT and angiogra-
phy at the same level of the right lower lobe in all subjects were correlated to
serum nitrite concentration and eNOS (endothelial nitric oxide synthase) expres-
sion as determined by immunostaining.
Results: The diameters of pulmonary vessels on thin-section CT were well cor-
related with nitrite concentrations in serum (r = 0.92, p < 0.001). Dilated pul-
monary vessels were significantly correlated with an increased eNOS expression
(r = 0.94, p < 0.0001), and the severity of pulmonary vessel tortuosity was found
to be well correlated with serum nitrite concentration (r = 0.90, p < 0.001).
Conclusion: The peripheral pulmonary vasculature in hepatopulmonary syn-
drome induced by CBLD was dilated on thin-section CT and on angiographs. Our
findings suggest that peripheral pulmonary vascular dilatations are correlated
with serum nitrite concentrations and pulmonary eNOS expression.
epatopulmonary syndrome consists of a triad of hepatic dysfunction
and/or portal hypertension, peripheral pulmonary vascular dilatation,
and hypoxemia in the absence of detectable primary cardiopulmonary
disease (1-3). Although the disease pathogenesis is not precisely known, reports show
that a vasoactive substance imbalance is likely to be responsible (4-9), and the leading
contender seems to be nitric oxide (4-12). Increased circulating nitric oxide or nitric
oxide synthase may account for the vasodilatation observed in hepatopulmonary
syndrome. Moreover, the development of an animal model of hepatopulmonary
syndrome, i.e., common bile duct ligation has provided us with a means of investigat-
ing the mechanism of intrapulmonary vascular dilatation (4-7, 9-14). However, most
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4investigations have been focused on intrapulmonary
vascular dilatation with respect to the microvasculature at
the capillary and precapillary levels (4-6, 10-12, 14),
though some authors (7, 14, 15) have documented
radiologic findings of hepatopulmonary syndrome at the
point of the peripheral pulmonary vasculature. However,
to our knowledge no study has been undertaken in which
pulmonary peripheral vessels were visualized on thin-
section CT and pulmonary angiography and correlated
with serum nitrite concentration and immunostainings. The
aim of this study was to investigate the correlations
between the radiologic finding of vascular dilatation with
serum nitrite concentration and endothelial nitric oxide
synthase (eNOS) expression in a rabbit model of
hepatopulmonary syndrome induced by common bile duct
ligation (CBDL).
MATERIALS AND METHODS
Animal Preparation and Methods
Experiments were performed on 17 New Zealand rabbits
weighing 3-3.5 kg using a protocol approved by our
institutional animal care and use committee. Animals were
housed under conditions of controlled temperature and
humidity (22+2℃/60% RH) and allowed ad libitum access
to water and laboratory chow. Rabbits underwent fasting
for 8 hours prior to anesthesia, and 0.5 mg of atropine
(Daehan Atropine; Daehan Pharmaceutical, Seoul, Korea)
was injected intramuscularly 30 minutes before operation
in order to prevent hypersecretion of mucus in the
bronchus. The rabbits were anesthetized by intramuscular
injection of 5 mg/kg of 2% xylazine hydrochloride
(Rompun; Bayer Korea, Seoul, Korea). Anesthesia was
maintained by an intramuscular injection of 25 mg/kg of
Ketamine hydrochloride (Ketalar; Yuhan Yanghang, Seoul,
Korea).
CBDL was administered to 13 rabbits under anesthesia.
After making an incision of 3 cm in the peritoneum
through a subcostal approach, the common bile duct was
ligated with No. 5 silk and the peritoneum was sutured.
Three weeks after CBDL, cirrhotic change had been
provoked providing a model of hepatopulmonary
syndrome. Four control rabbits were subjected to
laparatomy alone (sham operation) without CBD ligation.
After CBDL or sham operation, animals were administered
a daily injection of intramuscular cefotaxime at 20 mg/Kg
(Cefotaxime, Korean United Co., Seoul, Korea). Seven
rabbits of 13 CBDL were died during the period of the
experiment: four did not recover from anesthesia and three
died of ascitic fluid infections in the peritoneal cavity. Six
rabbits left in CBDL group and four left in the controls.
CT examination
Three weeks after CBDL or the sham operation, thin-
section CT scans were performed to detect pulmonary
vascular dilatation at the lower lobe 1 cm above the
diaphragm, in a steady-state condition, including a stable
heart rate, under anesthesia to prevent spontaneous
respiratory efforts. CT scans covering the entire thorax
were obtained using a Somatom Plus Scanner (Siemens
Medical System, Erlangen, Germany). The parameters
used were; a 2-mm-collimation, 1-to-1 pitch, 1-sec scan
time, 130 kVp, 220 mA, and a reconstruction interval of 1
mm with a window width of 1300 HU and a window level
at -350 HU. Imaging was obtained with a 8.2 ratio zoom
and 20-cm field-of-view.
Angiographic Examination
Rabbits were premedicated with 5 mg/kg of 2% xylazine
hydrochloride and ketamine hydrochloride 25 mg/kg
intramuscularly. Isoflurane (Aerane liquid, Ilsung, Seoul,
Korea) 1.5%-2.5% was used to maintain general anesthe-
sia. With a rabbit in a supine position, a surgical cut down
was performed to gain access to the right jugular vein, into
which a 4F Micropuncture sheath (Cook, Bloomington, IN,
USA) was introduced. The tip of the sheath was positioned
at the junction of the superior vena cava and right atrium.
In order to obtain biochemical parameters and serum
nitrite concentration, a 10 ml blood sample was obtained.
Ten milliliter of ioxaglate 320 (ioxaglate sodium: ioxaglate
meglumine = 1:3; Hexabrix 320; Guerbet, Paris, France;
320 mg of iodine per milliliter) was gently injected by hand
in the superior vena cava 5 ml/sec speed. Digital subtrac-
tion angiography was performed at a 25 degree left
posterior oblique position to inspect the right lower
pulmonary artery. Digital subtraction angiographic images
were obtained at a rate of 6 images per second.
Liver Function Test and Serum Nitrite Measurement
To evaluate hepatic laboratory function and to measure
serum nitrite (the stable end product of nitric oxide), blood
was obtained from CBD-ligated and sham-operated
rabbits. Before angiography, 10 ml of blood was collected
from the SVC, 8 ml of which was used for liver function
testing and 2 ml to determine serum nitrite concentrations
in blood. Whole blood was centrifuged at 6000 rpm for 3
min for serum preparation. The amount of nitrite in serum
was measured by using the Griess reaction, by adding 100
μ l of Griess reagent (1% sulfanilic acid, 0.1% naphthyleth-
ylenediamine dihydrochloride in 5% phosphoric acid) to
100 μ l samples. Samples were incubated at 25℃ for 10
minutes, and optical density was measured at 550 nm
(OD550) using a UV-VIS spectrophotometer (U-V-1201,
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calculated by comparison versus OD550 standard solutions
of sodium nitrite (2-100 μ M). 
Immunostaining
After lung removal, slices obtained from the right lower
lobe were fixed in 10% neutral buffered formalin for 24
hours. Processed and paraffin embedded tissue blocks were
sectioned at 4-6 μ m and placed on Snowcoat X-traTM
slides (Surgipath Co., Richmond, IL, U.S.A.). The sections
were deparaffinized with xylene, hydrated with decreasing
concentrations of ethanol, and then washed with phosphate
buffered saline (PBS). To retrieve nuclear antigen, the
sections were placed in Coplin jars, immersed in citrate
buffer for 20 minutes and then placed in microwave for 5
minutes. The Labelled Streptavidin Biotin Technique
(LSAB) detection system was used for immunostaining.
Briefly, pretreated slides were incubated in normal goat
serum for 30 minutes to block nonspecific binding. Primary
antibody (anti-eNOS, Transduction Lab. Lexinton, KY,
U.S.A.) was added and slides were incubated overnight for
2 hours at 25℃, washed with PBS for 2×10 minutes,
incubated with avidin biotin complex-linked peroxidase
solution, and then rinsed with PBS for 2×10 minutes. For a
mixture of 3-amino-9-ethylcarbazole, 0.01% hydrogen
peroxide, and Tris buffer 50 mmol/L, pH 7.2 was applied
until positive stains were detected. After the PBS wash, the
slides were mounted and examined under a microscope.
Negative control slices were processed in the same manner
but the primary antibody treatment was omitted. For
general inspection of lung morphology, slices were also
stained with conventional hematoxylin-eosin.
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Fig. 1. Hepatopulmonary syndrome (case 2) induced by 3
weeks after common bile duct ligation in a rabbit. 
A. Transverse thin-section CT scan obtained at the lower
lobe showing markedly dilated peripheral pulmonary vessel
(arrow) compared with vessels at the same level in Figs. 2,
3A. 
B. Pulmonary angiograph obtained at a 25 degree oblique
angle showing severe tortuous right basal arteries (arrow).
C. Immunostaining for endothelial nitric oxide synthase in
the right lower lobe near the level of A showing strong red
immunostaining both in vascular endothelial cells (arrows)
and in pneumocytes (arrowheads) (score 2).
CData Analysis
In thin-section CT scans, pulmonary vessels were
measured using a Vernier caliper (in millimeters to two
places of decimals) by two radiologists (S.K.Y, J.W.L),
blinded to the operation and all laboratory results. Three
to five peripheral pulmonary vessels were taken within 1
cm of the pleural surface, and 1 cm above the diaphragm
at the same level as the right lower lobe, in order to
prevent pulsation artifacts, which often occur in the left
lower lobe near the heart, in all subjects including the 4
controls. Each vessel of peripheral pulmonary vessels at
the right lower lobe was measured at the same level with a
Vernier caliper by the two radiologists, and the measure-
ment obtained were compared. The average values of the
diameter of vessels at this level were taken to determine
vascular dilatation as used in the serum nitrite concentra-
tion or eNOS expression investigation.
Angiographic images were analyzed by three radiologists
(K.N.L, S.K.Y, B.H.P) who were also unaware of operation
details and laboratory findings. We compared the tortuos-
ity of pulmonary vessels in the right lower lobe in
pulmonary angiographs in the both ten CBDL and control
rabbits. We scored tortuosity in 3 degrees (0, absent; 1,
dilatation of a vessel segment; 2, obvious vessel bowing);
decisions regarding findings were reached by consensus. 
The degree of immunostaining for eNOS expression was
graded into 3 groups; grade 0, no staining of parenchyma
or vessels; grade 1, slight staining of parenchyma and
vessels; and grade 2, strong staining of parenchyma and
vessels, as determined by a lung pathologist.
The diameter and the degree of tortuosity of vessels
were compared with the concentration of serum nitrite, the
degree of immunostaining for eNOS expression, and with
biochemical parameters (liver function tests (LFTs)). Data
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Fig. 2. Hepatopulmonary syndrome (case 1) induced 3
weeks after common bile duct ligation in a rabbit. 
A. Transverse thin-section CT scan obtained at the same
level of Fig. 1A shows moderately dilated peripheral
pulmonary vessels (arrow) versus vessels at the same
level in Figs. 1 and 3A. 
B. Pulmonary angiograph obtained at a 25 degree oblique
angle showing mild tortuous right basal arteries (arrow). 
C. Immunostaining for endothelial nitric oxide synthase in
the right lower lobe near the level of A showing slight red
immunostaining in vascular endothelial cells (arrows) and
in pneumocytes (arrowheads) (score 1).
Cwere analyzed using the student’s t test, by ANOVA. Non-
parametric correlation (Spearman) analysis was performed
using SAS/STAT software (SAS Institute Inc., Cary, NC,
USA) to determine the nature of the correlation between
pulmonary vessel diameter on CT, or the degree of vessel
tortuosity by angiography with serum nitrite concentra-
tion, eNOS expression, and LFT parameters. A p value of
< 0.05 was taken to indicate a statistically significant differ-
ence.
Cohen’s Kappa test was performed to determine interob-
server concordance with respect to pulmonary vessel
measurement using SAS/STAT software (SAS institute
Inc., Cary, NC, U.S.A.). Weighted kappa co-efficient
values were used to determine the levels of interobserver
agreement, and were considered as slight at < 0.2; fair =
0.21-0.4; moderate = 0.41-0.6; substantial = 0.61-0.8; or
almost perfect = 0.82-1.0.
RESULTS
In animals three weeks after CBDL we observed dilated
and tortuous pulmonary vessels. Dilated vessels ranged
from 1.3 to 2.2 mm in diameter (mean diameter ±
standard deviation, 1.6 mm±0.3) in the right lower lobes
(Figs. 1A, 2A); in contrast, the mean diameter of vessels in
control animals that underwent a sham operation was 0.9
mm±0.1 (Fig. 3A). The mean diameters and standard
errors of pulmonary vessel measurements in the right
lower lobes of hepatopulmonary syndrome (HPS) by CT
studies as determined by readers 1 and 2 were 1.6 mm±
0.2 and 1.5 mm±0.5, respectively. Mean diameters and
standard errors of vessel measurements in the right lower
lobes of control animals by CT as determined readers 1
and 2 were 0.8 mm±0.2 and 0.9 mm±0.1, respectively.
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Fig. 3. Control (case 7) - sham operation without common
bile duct ligation. 
A. Transverse thin-section CT scan obtained at the same
level as Figs. 1 and 2A, showing no evidence of a dilated
peripheral pulmonary vessel (arrow) compared with
vessels at the same level in Figs. 1 and 2A. 
B. Pulmonary angiographs obtained at a 25 degree oblique
angle showing no evidence of tortuosity of the right basal
arteries (arrow). 
C. Immunostaining for endothelial nitric oxide synthase in
the right lower lobe near the level of A. Vascular endothe-
lial cells show slight immunoreactivity but no definite
pneumocyte immunostaining (score 0).
CInterobserver agreement was thus moderate in terms of
pulmonary vessel measurement in HPS and in controls,
with weighted kappa coefficients of 0.58 (p < 0.05) and
0.52 (p < 0.05). We found that the diameters of pulmonary
vessels by CT were well correlated with both nitrite
concentration in serum (r = 0.92, p < 0.001) and with an
elevated eNOS expression (r = 0.94, p < 0.0001) (Table 1,
Figs. 1C, 2C, 3C, 4).
On pulmonary angiographs, right basal vessels were
tortuous in HPS versus the controls (Figs. 1B, 2B, 3B), and
the degree of tortuosity of pulmonary vessels was well
correlated with the serum nitrite concentration (r = 0.90, p
< 0.001). Serum nitrite was found to be elevated in the
CBDL operated group (n = 6), rather than in the controls
(n = 4) (p < 0.05).
In terms of the relationship between the degree of
intrapulmonary vasodilatation to hepatic dysfunction,
although laboratory findings showed hepatic dysfunction
versus the controls, no correlation was observed between
biochemical abnormalities and vascular dilatation or
pulmonary vessels tortuosity in HPS.
DISCUSSION
The pathogenesis of intrapulmonary vascular dilatation
in HPS remains an area of active investigation. In humans,
enhanced pulmonary production of nitric oxide in
pulmonary vasculature and in pneumocytes during the
development of vasodilatation has been studied by assess-
ing exhaled nitric oxide (17, 18). Although it is not known
whether observations in CBD-ligated animals reflect
human HPS, the development of an animal model of HPS
offers the possibility of accelerated progress in investiga-
tions of the mechanisms of intrapulmonary vascular
vasodilatation (4-12, 14). Recent work has shown that the
endothelial form of nitric oxide synthase is upregulated in
the pulmonary microcirculation and that this enhances
nitric oxide activity and vasodilatation in affected animals
(4-7, 11, 12, 14). Others have focused on alternative
contributors to intrapulmonary vascular dilatation, and it
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Table 1. Measurements and Tortuosity of Vessels as Seen on Thin-Section CT and Angiography, Concentration of Serum
Nitrite,  Immunostaining and Liver Function Test Results
Case Diameter Tortuosity  Concentration of Immunostaining Liver Function Test
(mm) (degree ) Serum Nitrite  (grade) Alk P AST ALT Total Bilirubin Direct Bilirubin
(μ M) (U/L) (U/L) (U/L) (mg/dL) (mg/dL)
CBDL
01 1.3 1 4.5 1 110 065 055 0.2 0.1
02 2.2 2 7.98 2 129 122 128 0.3 0.2
03 1.8 1 6.32 2 557 869 335 5.9 4.1
04 1.3 1 1.89 1 190 041 058 0.7 0.6
05 1.4 1 5.2 1 112 124 078 0.6 0.4
06 1.5 1 5.9 1 237 087 045 0.3 0.4
Control
07 0.9 0 1.19 0 015 019 024 0.2 0.1
08 0.9 0 1.56 0 018 098 058 0.4 0.3
09 0.8 0 1.4 0 019 046 034 0.3 0.3
10  0.8 0 1.59 0 020 112 066 0.7 1.1
Note.─ CBDL = common bile duct ligation, Alk P = alkaline phosphatase, AST = aspartate transaminase, ALT = alanine transaminase.
In tortuosity, numerical degree represents 0, absence; degree 1, dilatation of a vessel segment; degree 2, obvious vessel bowing.
Immunostaining numerical grade; 0 - represents absence; grade 1 - weak; grade 2 - strong.
For SI unit conversion (μ mole/L), multiply by 17.1.
Fig. 4. Correlation between peripheral pulmonary vessel diameter
and serum nitrite concentration in 6 animals 3 weeks after
common bile duct ligation and in four animals in the control
group. Peripheral pulmonary vessel diameter was found to
correlate significantly with serum nitrite concentration (r = 0.92, p
< 0.001).was found that an unexpected potential mediator of HPS,
endothelin-1, is overproduced in the CBDL liver and that
it is enhanced in the systemic circulation (4-6, 12), indicat-
ing that endothlin-1 might act as an endocrine vasodilator
and enhance endothelial nitric oxide production and
intrapulmonary vasodilatation (4-6, 12, 14, 19). 
In the present study, pulmonary vasodilatation was
investigated CBDL rabbits, as a HPS model for HPS. Three
weeks after CBDL, peripheral pulmonary vascular dilata-
tion was found on thin-section CT in all HPS animals.
Peripheral vessels were more dilated and tortuous by
pulmonary angiography than those in the sham-operated
controls, which suggests that CBDL rabbits provide a
suitable model for HPS. Although a CBDL rat HPS model
has shown intrapulmonary microvessel dilatation at the
precapillary and capillary levels, this model conceptually
appears inadequate for evaluating peripheral pulmonary
vasodilatation because of the size disparity.
A recent study showed that high-resolution CT may be a
less invasive radiologic method than angiography for the
detection of dilated pulmonary vessels in HPS (1, 16). The
degree of dilatation observed on CT was found to correlate
with the severity of gas exchange abnormalities in HPS,
which suggests that quantification of intrapulmonary
vasodilatation is possible (1). The present study also
showed a significant correlation between the degree of
vasodilatation and the degree of endothelial nitric oxide
synthase immunostaining, which is in agreement with the
findings of other investigators (4-11, 14). In addition, the
significant correlation found in the present study between
intravascular dilatation and the serum concentration of
nitrite, is in accord with the suggestion that nitric oxide is a
major causative factor in the pathophysiological develop-
ment of HPS (4-7, 11, 20).
Although pulmonary angiography is an invasive diagnos-
tic modality for the detection of intrapulmonary vasodi-
latation in HPS, it may be useful for the evaluation of
dilated vessel tortuosity. The present study shows tortuous
vascular dilatation is also significantly related to serum
nitrite concentration and eNOS expression in pulmonary
vasculature and pneumocytes. Most of the rabbits with
HPS after CBDL in our study showed tortuous right lower
basal arteries. However, the pulmonary angiographic
findings are different from published reports which
mentioned a diffuse spongy form appearance in the arterial
phase or even small arteriovenous communications (21,
22). We speculate that this rabbit model is inappropriate
for the evaluation of  small branches of peripheral
pulmonary vessels, except for those of the lower basal
artery.
In the present study, liver function tests showed hepatic
dysfunction, but no correlation was found between
biochemical abnormalities and HPS development, which
concurs with the findings of studies of hepatopulmonary
syndrome in man (23).
The present study has some limitations. The first being is
the small number of animals involved. The second is that
constitutive nitric oxide synthases like neuronal NOS
(nNOS) or inducible immunologic NOS (iNOS), were not
excluded as source of serum nitrite production.
Considering that the immunostaining of eNOS was found
in the endothelial cells of intrapulmonary vessels, some of
the serum nitric oxide must have been derived from this
eNOS. Thirdly, some CT scan images were blurred because
of tachypnea. However, we believe that this animal model
will prove useful for the evaluation of CBDL induced
intrapulmonary vascular dilatation in HPS. Moreover, the
application of thin-section CT to the evaluation of periph-
eral vessel in this study is believed to be valuable.
In conclusion, the peripheral pulmonary vasculature in
this CBDL rabbit model showed dilatation by thin-section
CT, tortuosity by pulmonary angiography, an increased
basal nitrite production and eNOS expression, which
suggest increased nitric oxide production. In summary,
these results suggest that eNOS plays an important role in
intrapulmonary vascular dilatation of this rabbit model of
hepatopulmonary syndrome induced by common bile duct
ligation.
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